Press

PANDA detects the error in the production process with the help of Artificial Intelligence and solves the biggest problems in industrial production. With the Plug & Play product DRIFT, PANDA offers an all-in-one system for minimizing plant downtimes and performance deficits in the production process. The High-Tech Gründerfonds (HTGF), Innovationsstarter Fonds Hamburg (IFH) and Business Angels are investing € 1.3 million in the Industrial AI startup. The capital is invested in product deve

Verovaccines enters into first collaboration with an international pharmaceutical company to jointly develop a veterinary vaccine The company was financed for the seed phase by High-Tech Gründerfonds, Business Angels and the founders as well as a seven-figure GO-Bio grant The goal is to develop and commercialize novel, cost-effective vaccines with high safety and efficacy for animal health The biotech start-up Verovaccines GmbH has signed the first cooperation agreement with a Japanese

Laclarée gets financial support from Kreaxi (France) and High-Tech Gründerfonds HTGF (Germany) alongside with Bpifrance and a pool of banks. The total amount raised will be 2m€, including non-dilutive financing. Laclarée develops adaptive eyeglasses for presbyopia correction. This seed investment will help developing the product to reach industrialisation and market readiness by the end of 2021. In Europe, more than 25 million presbyopes are unsatisfied with progressive lenses. Laclarée h

High-Tech Gründerfonds (HTGF) invests EUR 1 million in Datarade GmbH. Datarade is building a platform for companies to discover, compare and connect with already over 1,500 data providers across the globe. The invested capital will be used to grow the team in Berlin to further develop the platform. Companies increasingly use external data sources to fuel their analytics and predictions about their customers, markets and risks. But finding the right data sources amongst thousands of data provid

Seed X Liechtenstein AG and High-Tech Gründerfonds (HTGF) invest seven-figure euro amount EverReal offers real estate companies a digital platform for renting and selling of real estate The new capital will be invested into the further development of the platform, customer acquisition and the expansion of the team.   The two institutional venture capital companies HTGF and Seed X have invested a seven-figure euro amount in the further growth of EverReal GmbH, based in Munich. Foun

Qnami announced today the closing of a CHF 2.6M (USD 2.6M) seed round led by Venture Capital fund Quantonation and further supported by investiere, ZKB Start-up Finance and the High-Tech Gründerfonds. The funds will support the market entry of Qnami’s first product, a quantum microscope for inspection of magnetic materials at the nanoscale, and further developments of quantum sensing applications. Qnami is a Swiss start-up founded in November 2017. It has developed an innovative platform for

HQS enables chemical and material science companies with quantum chemical and advanced material simulations to use medium-term available NISQ processors UVC Partners, HTGF, and btov lead seed financing round Funding used to strengthen world-leading quantum simulation team From the development of more powerful batteries to highly efficient solar cells, finding new materials with specific predefined properties is of critical importance. So far our ability to design new materials using simu

High-Tech Gründerfonds (HTGF) has led a €1 Million seed round in Threedium Ltd. along with Kinisis Investment (KI), Sandhutch Ltd. and George Zarifis. The London-based tech startup has developed a 3D product configuration and visualisation platform. It will use the investment to further advance its 3D SaaS platform and expand into Germany, U.S. and other European markets. Threedium, which was founded in 2017, has built notable traction in the UK by supporting large enterprises such as Sainsb

Abalos Therapeutics announced today a EUR 12 million Series A financing round establishing its operations and leadership.  The Company’s objective is to develop new immuno-oncology therapeutics based on a specific arenavirus strain that preferentially infects and proliferates in cancer cells generating a strong anti-tumor immune response. The Series A round was co-led by Boehringer Ingelheim Venture Fund (BIVF) and Gruenderfonds Ruhr, with participation from NRW.BANK and High-Tech Gründe

The funding will be used for clinical evaluation of its technology; First application in vascular access for hemodialysis, prolonging the lives of patients with no other alternatives; The team has been expanded with seasoned biotech executives.   Every year, an estimated 300.000 hemodialysis patients worldwide die as they run out of medical alternatives. One of the main reasons for these deaths is failure of the vascular access site, the blood vessel where blood is removed, f

Berlin start-up Spherity develops decentralized identity management solutions for industrial IoT applications Companies, machines, smart devices and algorithms are given a digital identity ("digital twins") that is verifiable and globally addressable as a "URL for everything" These digital twins enable tamper-proof data sharing within highly complex and cross-enterprise business processes Proven use cases in the mobility, supply chain, or pharmaceutical industries demonstrate the benefi